BRITTNEY AUPPERLE: Open Payments
NPI 1477283109 · LATHAM, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,153 in 38 payments from 14 companies in 2025. Trend: 2023 $2,105 · 2024 $3,215 · 2025 $1,153
Food & beverage: $1,053Education: $100
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 4 | $247 |
| Boston Scientific Corporation | 3 | $210 |
| Sumitomo Pharma America, Inc. | 8 | $156 |
| PFIZER INC. | 5 | $89 |
| TOLMAR, INC. | 4 | $81 |
| Astellas Pharma US Inc | 2 | $65 |
| Myriad Genetic Laboratories, Inc. | 3 | $56 |
| Merck Sharp & Dohme LLC | 2 | $56 |
| ABBVIE INC. | 2 | $51 |
| Novartis Pharmaceuticals Corporation | 1 | $44 |
Products named: ERLEADA, Axonics, Xtandi, GEMTESA, RYBREVANT, JATENZO, PROLARIS, KEYTRUDA.
Industry payments across NY — which companies pay providers there.
